Wall Street Beat
Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014
Report: Allergan solicits Salix in bid to stymie hostile Valeant takeover
Ocular Therapeutix IPO reaches $75M with over-allotment
Bedford, Mass.-based Ocular Therapeutix (NSDQ:OCUL) raised $74.8 million though its initial public offering after underwriters fully exercised an over-allotment option to snag additional shares.
IPO or bust for emerging medtechs
Medtronic claims a 40% share of U.S. TAVI market with CoreValve
ConvaTec said to explore 2015 sale
Medtronic’s Q1 earnings beat The Street on modest sales bump
ElectroCore seeks commercial partners for non-invasive headache tech
ElectroCore said it tapped investment bank Piper Jaffray to help it court potential partners to commercialize the non-invasive vagus nerve stimulation treatment for headaches it’s developing.